StockWatch
·

TORRENT PHARMACEUTICALS LTD. Q4 FY25 Results

TORNTPHARMQ4 FY25 Results
Filing
MetricValue (₹ Cr)vs Q3 FY25
Revenue3.0K5.3%
Total Income2.9K3.5%
Expenditure2.3K4.7%
PBT665.003.8%
Net Profit498.001.0%
OPM31.77%17.46pp
NPM16.93%0.77pp
EPS14.711.1%
View full financials

Informational and educational content only. Not investment advice.